[Blistering autoimmune dermatoses (II): therapy].
Goebeler
Matthias
M
Klinik und Poliklinik für Haut- und Geschlechtskrankheiten, Bayerische Julius-Maximilians-Universität Würzburg. Goebeler_M1@klinik.uni-wuerzburg.de
Sitaru
Cassian
C
Zillikens
Detlef
D
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D012872:Skin Diseases, Vesiculobullous / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents